Stenocare Statistics

Total Valuation

Stenocare has a market cap or net worth of DKK 70.19 million. The enterprise value is 68.10 million.

Market Cap	70.19M
Enterprise Value	68.10M

Important Dates

The next estimated earnings date is Thursday, February 26, 2026.

Earnings Date	Feb 26, 2026
Ex-Dividend Date	n/a

Share Statistics

Stenocare has 43.20 million shares outstanding. The number of shares has increased by 80.73% in one year.

Current Share Class	43.20M
Shares Outstanding	43.20M
Shares Change (YoY)	+80.73%
Shares Change (QoQ)	-2.65%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	34.35M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	12.37
PB Ratio	32.15
P/TBV Ratio	32.15
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-2.77
EV / Sales	12.00
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.46, with a Debt / Equity ratio of 1.11.

Current Ratio	1.46
Quick Ratio	1.24
Debt / Equity	1.11
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-22.95

Financial Efficiency

Return on equity (ROE) is -233.84% and return on invested capital (ROIC) is -81.35%.

Return on Equity (ROE)	-233.84%
Return on Assets (ROA)	-63.17%
Return on Invested Capital (ROIC)	-81.35%
Return on Capital Employed (ROCE)	-632.84%
Revenue Per Employee	709,218
Profits Per Employee	-3.07M
Employee Count	8
Asset Turnover	0.32
Inventory Turnover	35.72

Taxes

In the past 12 months, Stenocare has paid 641,671 in taxes.

Income Tax	641,671
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -14.02% in the last 52 weeks. The beta is 0.52, so Stenocare's price volatility has been lower than the market average.

Beta (5Y)	0.52
52-Week Price Change	-14.02%
50-Day Moving Average	1.65
200-Day Moving Average	0.87
Relative Strength Index (RSI)	45.25
Average Volume (20 Days)	613,961

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Stenocare had revenue of DKK 5.67 million and -24.58 million in losses. Loss per share was -0.74.

Revenue	5.67M
Gross Profit	-13.51M
Operating Income	-17.70M
Pretax Income	-23.94M
Net Income	-24.58M
EBITDA	-16.80M
EBIT	-17.70M
Loss Per Share	-0.74

Full Income Statement

Balance Sheet

The company has 4.52 million in cash and 2.42 million in debt, giving a net cash position of 2.09 million or 0.05 per share.

Cash & Cash Equivalents	4.52M
Total Debt	2.42M
Net Cash	2.09M
Net Cash Per Share	0.05
Equity (Book Value)	2.18M
Book Value Per Share	0.06
Working Capital	2.74M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-3.39M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	-238.06%
Operating Margin	-311.90%
Pretax Margin	-421.88%
Profit Margin	n/a
EBITDA Margin	-296.05%
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Stenocare does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-80.73%
Shareholder Yield	-80.73%
Earnings Yield	-35.01%
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Stenocare has an Altman Z-Score of -3.67 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-3.67
Piotroski F-Score	5